Other Applications

Other Applications

Novoviah has demonstrated the success of the Novoleukin Test System as a ‘research only product’, firstly in Celiac Disease (Novoleukin-C, clinical validation stage); and is expanding to Type 1 Diabetes, and  other medical conditions associated with antigen-specific T cells (as listed below).

Novoviah’s aspiration is to have a Novoleukin Test System available for a wide range of antigens relevant to immune disease, therapies and vaccines, and to explore their clinical utility as diagnostics or monitoring tools.

If you are a pharmaceutical or research company developing, therapeutics or monitoring tools for indications where specific disease-associated antigen and T cell responses are implicated, contact us to discuss development of a highly sensitive Novoleukin test system specific to your indication.